Université de Bordeaux
FHU SMART Small Artery Disease transdisciplinary project
Cluster of excellence

Prof. Jean-Michel Boiron

Prof. Jean-Michel Boiron is professor in clinical hematology, transfusion, at the University Hospital and University of Bordeaux. He is currently affiliated with Inserm U1034, with a particular focus on enhancing exploitation and dissemination of research.

Summary CV

Jean-Michel Boiron, MD PhD, born in 1961, is Professor of Hematology and Transfusion at the University Hospital and University of Bordeaux. He is affiliated with Inserm U1034 and currently in “administrative mobility” from the EFS (French national blood bank). He is senior executive master of ESCP Europe. His professional background is as follows: Lecturer (1993-); University Professor (2008-); Hospital Doctor (grafts Sector Hematology), Bordeaux University Hospital (1993-2004); Director of the French national blood bank (EFS) for the Aquitaine Limousin region (550 FTE, 2004-2012), Head of the EFS (French national blood bank) National Training Agency (2014-). His medical areas of expertise are: Hematology, Hematopoietic Stem Cell Transplants, Cell Therapy, Transfusion. As director of a public institution, he developped skills in management, quality control, total quality management, and project management. Orientation and exploitation of research activities, innovation and societal impacts of research are important current topics of interest in which he proposes to invest time for SMART (as he has been doing in the past 2 years for INSERM U1034).

Selected References


1. Neonatal sex and weight influence CD34(+) cell concentration in umbilical cord blood but not stromal cell-derived factor 1-3'A polymorphism. Bijou F, Ivanovic Z, Fizet D, Dazey B, Boiron JM, Lafarge X. Cytotherapy. 2015 Jan;17(1):68-72.

2. Long-term repopulating hematopoietic stem cells and "side population" in human steady state peripheral blood. Brunet de la Grange P, Vlaski M, Duchez P, Chevaleyre J, Lapostolle V, Boiron JM, Praloran V, Ivanovic Z. Stem Cell Res. 2013 Jul;11(1):625-33.

3. Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells. Duchez P, Chevaleyre J, Brunet de la Grange P, Vlaski M, Boiron JM, Wouters G, Ivanovic Z. Transfusion. 2013 Sep;53(9):2012-9.

4. JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone. Godfrey AL, Chen E, Pagano F, Ortmann CA, Silber Y, Bellosillo B, Guglielmelli P, Harrison CN, Reilly JT, Stegelmann F, Bijou F, Lippert E, McMullin MF, Boiron JM, Döhner K, Vannucchi AM, Besses C, Campbell PJ, Green AR.Blood. 2012 Sep 27;120(13):2704-7.

5. Definitive setup of clinical scale procedure for ex vivo expansion of cord blood hematopoietic cells for transplantation. Duchez P, Chevaleyre J, Vlaski M, Dazey B, Milpied N, Boiron JM, Ivanovic Z. Cell Transplant. 2012;21(11):2517-21



TOP